Affiliation:
1. Centre for Pharmaceutical Innovation, UniSA Clinical and Health Sciences, University of South Australia, Adelaide, SA 5000, Australia
Abstract
Intracellular bacteria are inaccessible and highly tolerant to antibiotics, hence are a major contributor to the global challenge of antibiotic resistance and recalcitrant clinical infections. This, in tandem with stagnant antibacterial discovery, highlights an unmet need for new delivery technologies to treat intracellular infections more effectively. Here, we compare the uptake, delivery, and efficacy of rifampicin (Rif)-loaded mesoporous silica nanoparticles (MSN) and organo-modified (ethylene-bridged) MSN (MON) as an antibiotic treatment against small colony variants (SCV) Staphylococcus aureus (SA) in murine macrophages (RAW 264.7). Macrophage uptake of MON was five-fold that of equivalent sized MSN and without significant cytotoxicity on human embryonic kidney cells (HEK 293T) or RAW 264.7 cells. MON also facilitated increased Rif loading with sustained release, and seven-fold increased Rif delivery to infected macrophages. The combined effects of increased uptake and intracellular delivery of Rif by MON reduced the colony forming units of intracellular SCV-SA 28 times and 65 times compared to MSN-Rif and non-encapsulated Rif, respectively (at a dose of 5 µg/mL). Conclusively, the organic framework of MON offers significant advantages and opportunities over MSN for the treatment of intracellular infections.
Funder
Australian Research Council
Reference35 articles.
1. Nanocarriers for antibiotics: A promising solution to treat intracellular bacterial infections;Abed;Int. J. Antimicrob. Agents,2014
2. Targeting the hard to reach: Challenges and novel strategies in the treatment of intracellular bacterial infections;Kamaruzzaman;Br. J. Pharmacol.,2017
3. Intracellular Penetration and Effects of Antibiotics on Staphylococcus aureus Inside Human Neutrophils: A Comprehensive Review;Bongers;Antibiotics,2019
4. Thi, E.P., Lambertz, U., and Reiner, N.E. (2012). Sleeping with the Enemy: How Intracellular Pathogens Cope with a Macrophage Lifestyle. PLOS Pathog., 8.
5. Staphylococcus aureus Small Colony Variants (SCVs): News From a Chronic Prosthetic Joint Infection;Loss;Front. Cell. Infect. Microbiol.,2019
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献